SGI Stock Forecast & Price Target

Somnigroup International is viewed positively because the LEG acquisition appears immediately accretive, with management raising 2026 revenue guidance to $8.80-$8.85B, adj. EBITDA to $1.51B, and EPS to $2.95-$3.25, while also signaling about $0.40 of Year 1 EPS accretion before synergies. The fundamental case is strengthened by the $75M synergy opportunity, including $35M from sourcing, $30M from operations, and $10M from innovation, alongside tighter supplier standards at Mattress Firm and premium marketing that should push more volume toward LEG's high-quality spring and foam components. Input-cost headwinds are expected to reverse with pricing, the acquisition should reduce leverage and support buybacks, and management still believes it can reach $5.15 of EPS by 2028 despite softer sales trends.

Somnigroup International is facing a fundamentally weaker backdrop as the bedding industry has declined for 4 straight years (2022-2025) and may be entering a 5th year of declines, while consumer sentiment sits near a 10-year low and store traffic remains the key bottleneck despite strong closing rates. Management’s lowered full-year guidance underscores that pressure: global bedding industry sales are expected to be -MSD% y/y, net sales were reduced by $200M to about $7.6B, and adjusted EPS was cut to $2.85-$3.15 from $3.00-$3.40. Although gross margin is still expected to exceed 45% on +100bps of efficiencies and synergies, risks from commodity costs, competition, retailer relationships, and weak macro conditions suggest limited visibility and a negative setup.